The KLHL22 Monoclonal Antibody (PACO10136) is a valuable tool for researchers studying KLHL22, a protein involved in the regulation of protein degradation pathways within the cell. This antibody, produced in mice, has high specificity and sensitivity for detecting KLHL22 in human samples, making it ideal for use in Western blot and immunohistochemistry experiments.KLHL22 is a substrate-specific adaptor protein that plays a key role in the ubiquitin-proteasome system, which is essential for maintaining cellular homeostasis by targeting proteins for degradation. Dysregulation of this system has been implicated in various diseases, including neurodegenerative disorders and cancer.
By studying KLHL22 and its interactions with other proteins, researchers can gain insights into the mechanisms underlying these diseases and potentially identify novel therapeutic targets.Overall, the KLHL22 Monoclonal Antibody (PACO10136) is a valuable tool for researchers interested in understanding the role of KLHL22 in cellular processes and disease pathogenesis. Its high specificity and sensitivity make it a reliable reagent for studying KLHL22 in a variety of experimental settings.
